HS/KN-kod 30021010 är utanför tillämpningsområdet för EUDR-förberedelse.
Antisera(2012-2016);Antisera(2002-2011);Antisera(1988-2001) Den indexerade omfattningsmotorn returnerar Out of scope för denna kod. No Annex I scope match was found for this indexed CN code.
Varför denna referenssida ger det svaret.
- Kodbeskrivning
- Antisera(2012-2016);Antisera(2002-2011);Antisera(1988-2001)
- Grund i bilaga I
- Ingen direkt post i bilaga I
- Källgrund
- Regulation (EU) 2023/1115 Annex I and CN 2026 index
Överordnade, underordnade och närliggande rader.
Biblioteksvyn är till för referensnavigering. Använd kontrollen när du vill köra en annan kod som en åtgärd.
30farmaceutiska produkterout3002human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excl. yeasts) and similar productsout300210antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processesout30021091haemoglobin, blood globulins and serum globulins(2012-2016);haemoglobin, blood globulins and serum globulins(2002-2011);haemoglobin, blood globulins and serum globulins(1988-2001)out30021095blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2012-2012);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2002-2011);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(1988-2001)out30021098blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins)out30021099blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of animal blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2012-2012);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of animal blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2002-2011);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of animal blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(1988-2001)out
Vad detta betyder för förberedelsen.
Denna rad utlöser inte direkt bevisinsamling i det aktuella omfattningsresultatet.
Regulation (EU) 2023/1115 Annex I — relevant productshämtad 2026-08-06Commission Delegated Regulation (EU) 2026/2102 amending Annex I to Regulation (EU) 2023/1115hämtad 2026-09-24Eurostat Comext Combined Nomenclature codelist (CXT_NC v11.0)hämtad 2026-08-06Eurostat Comext partner country codelist (CXT_FREE_ISO)hämtad 2026-08-06Eurostat Comext DS-045409 — EU trade since 1988 by HS2-4-6 and CN8hämtad 2026-08-06Commission Implementing Regulation (EU) 2025/1093 — country benchmarkinghämtad 2026-08-06Regulation (EU) 2025/2650 amending Regulation (EU) 2023/1115 as regards certain obligations of operators and tradershämtad 2025-12-26Commission Implementing Regulation (EU) 2026/1565 amending Implementing Regulation (EU) 2024/3084 (EUDR information system)hämtad 2026-08-08